Trial Profile
Phase II Study on TAXOL in Bronchioalveolar Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Lung cancer
- Focus Biomarker; Therapeutic Use
- 17 Sep 2005 New trial record.